Cardiologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Chiropractor providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dentist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dermatologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Family Physician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
OB-GYN providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Ophthalmologist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Orthopedic Surgeon providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Pediatrician providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Physical Therapist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Podiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Psychiatrist providers include doctors, nurses, nurse practitioners, and physician assistants. They often maintain long-term relationships with you and advise and treat you on a range of health related issues.
Dr. Singavi’s clinical interests include solid tumors and hematologic disorders (both malignant and non-malignant – thrombotic/bleeding disorders/etc.). His special interests include breast cancer, gastrointestinal cancers, brain tumors, and lung cancer.
When not working, Dr. Singavi enjoys spending time with his family, traveling, and watching sports.
"My father has been a patient of Dr Singavi for 3 years. Dr Singavi is an absolute gem! He is compassionate and very knowledgeable. He takes his time to listen to patient concerns and help the patient/family understand the treatment plan. I can’t say enough how grateful I am my father is in his care. It’s so rare to find a doctor that is both skilled in his field and has top notch bed side manor. Dr Singavi is both!!" -Laura
"Dr. Singavi is the most amazing Dr. He is kind, compassionate, and takes all the time in the world to make sure you understand your condition, and your treatment plan. His entire office staff is also very compassionate and carring. If you have to see an Oncologist, and let's face it, nobody wants to, Dr. Singavi and his staff are the people you want to be with during your care." -Sandy
Krystal is an Acute Care Nurse Practitioner and is board certified with the American Nurses Credentialing Center. She specializes in Bio-identical Hormone Replacement Therapy, Pain Management, Internal Medicine, and Addiction Medicine. She completed her Bachelor's of Science in Nursing and Master’s of Science in Nursing at Grand Canyon University. Krystal was an ICU nurse for over 10 years, this gave her the unique experience to really connect and bond with her patients, ultimately exceeding her patient's expectations, calm their fears and deliver exceptional medicine.
“Very personal and kind!! She really wanted to know about me and was very knowledgeable on what I was doing!! Asked lots of questions. I was very comfortable with her to trust what she was doing!”
Krystal Cherapan, ACNP-BC
Nurse Practitioner
6328 East Brown Road
Suite 106
Mesa, AZ 85205
5.0(20)
4.88
(18)
Dr. Shantha Kumar, MD
Cardiovascular Disease Physician 9.3 mi
Dr. Shantha Kumar is an interventional cardiologist specializing in Interventional Cardiology and Adult Cardiology. He received his medical degree from Bangalore Medical College and has been in practice for more than 20 years. Dr. Kumar is qualified to deliver comprehensive care for your cardiovascular system and heart. Dr. Kumar may see patients for symptoms like difficulty breathing, dizziness or chest pain. Cardiovascular issues that may be identified and cared for by a cardiologist can include congenital heart defects, angina, arrhythmia, heart failure, rheumatic heart disease, heart aneurysms and coronary artery disease.
Daniel Skinner, MD, is board-certified in dermatology and Mohs micrographic surgery. He provides expert care at Skin Cancer Specialists, located in Mesa, Arizona.
Dr. Skinner is a 5th-generation Arizonan who grew up in Mesa and graduated from Mountain View High School. He went on to attend Brigham Young University in Provo, Utah, where he graduated with a degree in business management. He then attended the University of Arizona College of Medicine in Tucson, where he developed an interest in dermatologic surgery.
During medical school, he was a leader and volunteer in many different medical school organizations. He completed a one-year internship in internal medicine at Banner Good Samaritan Medical Center in Phoenix, Arizona, and a three-year dermatology residency at the University of Missouri in Columbia, where he served as chief resident in his final year. He has presented research at many local and national meetings and has published research on the use of Mohs surgery for rare skin cancer, as well as a book chapter on dermabrasion.
Dr. Skinner concluded his training with an intensive one-year fellowship in Mohs micrographic and dermatologic surgery in Birmingham, Alabama, with Dr. Christopher Harmon, one of the nation's leading Mohs surgeons. Dr. Skinner has performed over 10,000 skin cancer surgeries. In addition to training in Mohs surgery and skin cancer removal, he has expertise in facial reconstruction after skin cancer removal.
Dr. Skinner is currently the president of the Phoenix Dermatology Society and on the board of directors of the Arizona Dermatology and Dermatologic Surgery Society. In addition, he is very active in volunteer work for his church and enjoys spending time playing and watching sports.
When he is not at work, Dr. Skinner enjoys spending time with his wife, Marie, and their six children.
Mohs Micrographic and Dermatologic Surgery - Surgical Dermatology Group - Birmingham, AL Fellowship
University of Missouri - Columbia, MO Residency - Dermatology
University of Arizona - Tucson, AZ Medical School
Brigham Young University - Provo, UT BS Business Management
Certifications/Memberships:
American College of Mohs Surgery - Fellow
American Academy of Dermatology - Fellow
American Medical Association - Member
Arizona Medical Association - Member
Arizona Dermatology and Dermatologic Surgery Society - Member
Phoenix Dermatology Society - Member
American Board of Dermatology - Board Certified
Awards/Recognition:
Dr. Skinner has consistently been recognized by his patients and peers for his excellence in dermatology and patient care. He has received the Patients' Choice Award, the Compassionate Doctor Recognition, and the On-time Award by the website, vitals.com, which is rated and awarded by patients. The vitals.com website states the following: "This award recognizes doctors who make a difference in the lives of their patients. This honor is given to those physicians who have received near perfect scores as voted by their patients." In addition, Dr. Skinner was elected by his peers to be the President of the Phoenix Dermatology Society, a group of over 150 dermatologists in the Phoenix metropolitan area.
Mohammad Nasser, MD, founder of Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona, is a board-certified internal medicine physician and population health specialist. Dr. Nasser has a special interest in complex patient care, gaining extensive experience as a hospitalist and internist providing care in hospitals, long-term acute care centers, and subacute rehabilitation.
With a well-known reputation as an exceptional health care innovator, Dr. Nasser creates and implements programs that improve the quality of care and diminish costs for hospitals and skilled nursing facilities.
Born and raised in Michigan, Dr. Nasser received his bachelor’s degree from Wayne State University in Detroit Michigan. After receiving his medical degree at the American University of the Caribbean School of Medicine in Sint Maarten, he completed his internship and internal medicine residency at Ascension Providence Hospital, Michigan State University College of Human Medicine in Grand Rapids, Michigan.
Dr. Nasser is known for numerous accomplishments in his field. He was the medical director at Arkos Health and managed more than 200,000 patients through his transitional care management program.
During his tenure at Arkos Health, Dr. Nasser developed an inpatient program that shortened hospital stays and mobilized patients to the next level of care. He also implemented a skilled nursing program that improved the post-discharge process.
As a respected author, Dr. Nasser published articles in medical journals as well as the well-known book, “Management of Chronic Kidney Disease.” He also served as a manuscript reviewer for medical journals, including the Journal of the American College of Cardiology.
Dr. Nasser is a proud member of the Phoenix community, where he welcomes patients and is highly regarded for his quality of care and leadership roles.
Board-certified internal medicine physician, William Nassour, MD, provides integrative health care at Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona. His expertise includes all aspects of adult health care, however, he has a special interest in cardiovascular disease, diabetes, geriatrics, and post-acute care.
Dr. Nassour is well-respected for go-to advice, with peers seeking his assistance and guidance in geriatrics and post-acute care, and patients depending on his understanding to provide honest evaluations and recommend individualized care.
Dr. Nassour received his medical degree from Tishreen University in Latakia, Syria, and completed his residency training in internal medicine at the New York University Langone Health in Brooklyn, New York.
With more than a decade of experience as a practicing physician in hospital medicine, including outpatient and subacute care, Dr. Nassour has developed extensive knowledge and skills that help him better understand each patient and create effective treatment plans.
He has successfully filled leadership roles as the medical director in different medical settings. He also remains active on various hospital committees.
Dr. Nassour welcomes new and current patients at Leading MDs, where he collaborates with each person to improve their health and well-being.
Dr. Sanjeev Gopal is a board-certified specialist in medical oncology and hematology with Arizona Center for Cancer Care and Virginia G. Piper Cancer Care Network.
With offices in Apache Junction, Mesa and Gilbert, Dr. Gopal is committed to providing the highest level of care with a priority of treating each patient and their families with utmost respect. It is important to Dr. Gopal to not only prolong lives of his patients, but to improve the quality of their lives.
"Dr Gopal is fabulous! He is really focused on you and what you are going through! Compassionate and knowledgeable!" -Pat
"Dr. Gopal and his staff are without a doubt the EXCEPTION TO TODAY'S IMPRESSION OF MEDICAL PROVIDERS! Dr. Gopal obviously took the time to hire his staff, because they are just as compassionate, caring, kind and loving as him. Trust me, I am qualified to make these statements; not my first rodeo, ya'll. I don't typically take the time for reviews, but for Dr. Gopal, I absolutely will make an exception as he deserves all the recognition for who he simply is, as a person (I think). Dr. Gopal took a personal interest in my care from the moment I was referred to him. "Bedside manner?" Dr. Gopal treated me like a "person" he cares for, like family. Therefore, that term is not relevant. If you ask me, that is a good thing!...' -Heidi
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Mohammad Nasser, MD, founder of Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona, is a board-certified internal medicine physician and population health specialist. Dr. Nasser has a special interest in complex patient care, gaining extensive experience as a hospitalist and internist providing care in hospitals, long-term acute care centers, and subacute rehabilitation.
With a well-known reputation as an exceptional health care innovator, Dr. Nasser creates and implements programs that improve the quality of care and diminish costs for hospitals and skilled nursing facilities.
Born and raised in Michigan, Dr. Nasser received his bachelor’s degree from Wayne State University in Detroit Michigan. After receiving his medical degree at the American University of the Caribbean School of Medicine in Sint Maarten, he completed his internship and internal medicine residency at Ascension Providence Hospital, Michigan State University College of Human Medicine in Grand Rapids, Michigan.
Dr. Nasser is known for numerous accomplishments in his field. He was the medical director at Arkos Health and managed more than 200,000 patients through his transitional care management program.
During his tenure at Arkos Health, Dr. Nasser developed an inpatient program that shortened hospital stays and mobilized patients to the next level of care. He also implemented a skilled nursing program that improved the post-discharge process.
As a respected author, Dr. Nasser published articles in medical journals as well as the well-known book, “Management of Chronic Kidney Disease.” He also served as a manuscript reviewer for medical journals, including the Journal of the American College of Cardiology.
Dr. Nasser is a proud member of the Phoenix community, where he welcomes patients and is highly regarded for his quality of care and leadership roles.
Board-certified internal medicine physician, William Nassour, MD, provides integrative health care at Leading MDs in Goodyear, Tempe, Sun City, and Mesa, Arizona. His expertise includes all aspects of adult health care, however, he has a special interest in cardiovascular disease, diabetes, geriatrics, and post-acute care.
Dr. Nassour is well-respected for go-to advice, with peers seeking his assistance and guidance in geriatrics and post-acute care, and patients depending on his understanding to provide honest evaluations and recommend individualized care.
Dr. Nassour received his medical degree from Tishreen University in Latakia, Syria, and completed his residency training in internal medicine at the New York University Langone Health in Brooklyn, New York.
With more than a decade of experience as a practicing physician in hospital medicine, including outpatient and subacute care, Dr. Nassour has developed extensive knowledge and skills that help him better understand each patient and create effective treatment plans.
He has successfully filled leadership roles as the medical director in different medical settings. He also remains active on various hospital committees.
Dr. Nassour welcomes new and current patients at Leading MDs, where he collaborates with each person to improve their health and well-being.
Dr. Sanjeev Gopal is a board-certified specialist in medical oncology and hematology with Arizona Center for Cancer Care and Virginia G. Piper Cancer Care Network.
With offices in Apache Junction, Mesa and Gilbert, Dr. Gopal is committed to providing the highest level of care with a priority of treating each patient and their families with utmost respect. It is important to Dr. Gopal to not only prolong lives of his patients, but to improve the quality of their lives.
"Dr Gopal is fabulous! He is really focused on you and what you are going through! Compassionate and knowledgeable!" -Pat
"Dr. Gopal and his staff are without a doubt the EXCEPTION TO TODAY'S IMPRESSION OF MEDICAL PROVIDERS! Dr. Gopal obviously took the time to hire his staff, because they are just as compassionate, caring, kind and loving as him. Trust me, I am qualified to make these statements; not my first rodeo, ya'll. I don't typically take the time for reviews, but for Dr. Gopal, I absolutely will make an exception as he deserves all the recognition for who he simply is, as a person (I think). Dr. Gopal took a personal interest in my care from the moment I was referred to him. "Bedside manner?" Dr. Gopal treated me like a "person" he cares for, like family. Therefore, that term is not relevant. If you ask me, that is a good thing!...' -Heidi
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.
Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.
In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.
During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.
Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.
Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.
PHILOSOPHY
I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.
RESEARCH PUBLICATIONS
Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358. 2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282. 3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228 4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240. 5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053
/assets/docs/441981.png)
/assets/docs/441977.png){kind=small}
/assets/images/provider/photos/2288383.jpg)
/assets/images/provider/photos/2288383.jpg)